A multicenter, randomized, double-blind, double dummy, parallel group, dose ranging study of subcutaneous SR123781A with an enoxaparin calibrator arm in the prevention of venous thromboembolism in patients undergoing elective total hip replacement surgery.

Trial Profile

A multicenter, randomized, double-blind, double dummy, parallel group, dose ranging study of subcutaneous SR123781A with an enoxaparin calibrator arm in the prevention of venous thromboembolism in patients undergoing elective total hip replacement surgery.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 21 Nov 2016

At a glance

  • Drugs Enoxaparin sodium; SR 123781
  • Indications Thromboembolism
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms DRIVE
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2006-000152-41).
    • 09 Dec 2008 Additional trial identifier EudraCT2006-000152-41 reported by ClinicalTrials.gov.
    • 15 Apr 2008 Primary endpoint results have been published
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top